Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava, F Concha-Benavente… - … for ImmunoTherapy of …, 2015 - Springer
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …
被引用次数：2 相关文章

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava… - Journal for …, 2015 - jitc.biomedcentral.com
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava, F Concha-Benavente… - 2015 - jitc.bmj.com
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, R Srivastava… - … for Immunotherapy of …, 2015 - europepmc.org
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava… - … for Immunotherapy of …, 2015 - ncbi.nlm.nih.gov
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …

[引用][C] Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava, F Concha-Benavente… - … for ImmunoTherapy of …, 2015 - infona.pl
Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head
and neck cancer patients × Close The Infona portal uses cookies, ie strings of text saved by …

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava, F Concha-Benavente… - 2015 - researchgate.net
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava… - … for ImmunoTherapy of …, 2015 - go.gale.com
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava, F Concha-Benavente… - 2015 - core.ac.uk
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

S Trivedi, RM Srivastava… - Journal for …, 2015 - search.proquest.com
EGFR is frequently overexpressed on several cancers, and two targeted antibodies are FDA
approved but differ by isotype. Cetuximab (IgG1 isotype) has been shown to be effective at …